Wutah pendapatan taun lumaku: Kazia Therapeutics (KZIA)

Logo perusahaan publik Kazia Therapeutics Ltd (KZIA)

Kazia Therapeutics focuses on the treatment of glioblastomas and rare oncological diseases, relying on payments from hospitals and insurance providers. The company enhances drug discovery efficiency through robotic genome analysis and automated cell imaging. Currently, Kazia Therapeutics is developing drugs designed to cross the blood-brain barrier. The TTM annual revenue change illustrates sales dynamics, where the 164.40 level reflects the current magnitude.

Kazia Therapeutics Limited (KZIA): Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 11.02.2024 nganti 19.11.2026

Kazia Therapeutics Limited - rincian analitis lan metrik utama (KZIA)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:kaziatherapeutics.com
Produk merek kaziatherapeutics.com

Year-over-year (TTM) sales growth measures revenue dynamics over the last twelve months relative to the same period last year, allowing investors to assess business scaling rates and the risk of capital stagnation. By analyzing TTM revenue volatility compared to the previous year, one can benchmark the financial results of Kazia Therapeutics (KZIA) against the operational efficiency of their oncology facilities and the modernization process of their sterile booths.

Karo sapa Kazia Therapeutics saingan

Incyte Pharma - Wutah dodolan YoY sajrone rolas wulan kepungkur|HUTCHMED Corp - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Nuvation Bio Inc.|DAWN: Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Monopar Pharma MNPR|Wutah pendapatan YoY sajrone 12 wulan kepungkur INBX|Wutah pendapatan taun lumaku I-Mab Biopharma IMAB|Wutah pendapatan YoY sajrone 12 wulan kepungkur FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Nuvectis Pharma, Inc. - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CHRS (Coherus BioSciences)|Corbus Pharma - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur CRDF (cardiffoncology.com)|BYSI: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku BioAtla Corp (BCAB)|Wutah dodolan YoY sajrone rolas wulan kepungkur Lixte Biotechnology Holdings, Inc.|CTXR: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) CLRB|Wutah dodolan YoY (TTM) BioLineRx Corporation (BLRX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Wutah dodolan taun lumaku|SLXN: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku NuCana|CMRX: Wutah dodolan YoY (TTM)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Wutah dodolan YoY (TTM)|KRON: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Kintara (KTRA)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Oncternal ONCT|Portage Biotech - Wutah pendapatan YoY sajrone 12 wulan kepungkur